Here's how much Moderna's CEO makes compared to competitors - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Moderna announced very promising results for their long-awaited COVID-19 vaccine. Here's how much the company's CEO makes compared to competitors.

a week before Moderna's results, on November 9, with a similar 90% effectiveness rate.

In the table below, we compared Moderna against two different types of companies: mature, established pharma giants and smaller biotech startups similar in scale to Moderna. We also show compensation for three firms from Moderna's compensation peer group as reported in the company's — Incyte Corp., Bluebird Bio, and Nektar Therapeutics. A compensation peer group is a group of competitors that companies use to understand how its competition is paying executives to inform their own compensation decisions.

In the chart below, we show compensation for CEOs of Moderna and other pharmaceutical and biotech firms as disclosed in each firm's most recent proxy statement, split out by element. Hold your cursor over the labels at the top to highlight the different parts of the executives' compensation, and reference the bulleted list below for more information on each compensation element.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

'Impeachment of (Articles ) and Conviction for (Articles ) by U.S. House 2/3rds Vote Constituting Conviction Impeached With Judgement not Extending further than removal from Office upon Impeachment for and Conviction of Articles Same. '

good

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 729. in BE

Belgique Dernières Nouvelles, Belgique Actualités